References

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva: World Health Organization; 2013.

A new version of this title is available

This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention.

Show details

Contents

< Prev Next >

References

1.: Arbyn M, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30 Suppl 5:F88–99. [PubMed: 23199969]
2.: De Vuyst H, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. British Journal of Cancer. 2012;107(9):1624–1630. [PMC free article: PMC3493776] [PubMed: 23033006]
3.: Denny L, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstetrics & Gynecology. 2008;111(6):1380–1387. [PubMed: 18515522]
4.: Joshi S, et al. Screening of cervical neoplasia in HIV-infected women in India. AIDS. 2013;27(4):607–615. [PubMed: 23079814]
5.: Zhang HY, et al. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pacific Journal of Cancer Prevention. 2012;13(1):91–96. [PMC free article: PMC3809115] [PubMed: 22502720]
6.: Santesso N, et al. World Health Organization Steering Committee for Recommendations on Use of Cryotherapy for Cervical Cancer Prevention. World Health Organization Guidelines: use of cryotherapy for cervical intraepithelial neoplasia. International Journal of Gynecology & Obstetrics. 2012;118(2):97–102. [PubMed: 22727415]
7.: WHO guidelines: use of cryotherapy for cervical intraepithelial neoplasia. Geneva: World Health Organization, Department of Reproductive Health and Research; 2011. [24 October 2013]. http://www.who.int/reproductivehealth/publications/cancers/9789241502856/en/ [PubMed: 23741775]
8.: WHO guidelines for treatment of cervical intraepithelial neoplasia 2–3 and glandular adenocarcinoma in situ: Cryotherapy, large loop excision of the transformation zone (LEEP/LLETZ), and cold knife conization. Geneva: World Health Organization; (in process) [PubMed: 24901204]
9.: Sellors JW, Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginner's manual. France: International Agency for Research on Cancer, World Health Organization; 2003. [24 October 2013]. http://screening.iarc.fr/doc/Colposcopymanual.pdf.
10.: Comprehensive cervical cancer control: a guide to essential practice (C4-GEP). Geneva: World Health Organization, Department of Reproductive Health and Research and Department of Chronic Diseases and Health Promotion; 2006. [20 August 2013]. http://www.who.int/reproductivehealth/publications/cancers/9241547006/en/ [PubMed: 25642554]
11.: WHO handbook for guideline development. Geneva: World Health Organization; 2010. [6 August 2013]. http://www.who.int/hiv/topics/mtct/grc_handbook_mar2010_1.pdf.
12.: WHO handbook for guideline development. Geneva: World Health Organization; 2012. [6 August 2013]. http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf.
13.: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions Version 5.1.0. The Cochrane Collaboration; [6 August 2013]. updated March 2011 (www.cochrane-handbook.org.
14.: Guyatt GH, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926. [PMC free article: PMC2335261] [PubMed: 18436948]
15.: Schünemann HJ, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–1110. [PMC free article: PMC2386626] [PubMed: 18483053]
16.: Bradley J, et al. Women's perspectives on cervical screening and treatment in developing countries: experiences with new technologies and service delivery strategies. Women and Health. 2006;43(3):103–121. [PubMed: 17194680]
17.: Melnikow J, et al. Management of the low-grade abnormal Pap smear: what are women's preferences? Journal of Family Practice. 2002;51(10):849–855. [PubMed: 12401153]
18.: Frederiksen ME, Lynge E, Rebolj M. What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review. BJOG: An International Journal of Obstetrics and Gynaecology. 2012;119(1):7–19. [PubMed: 21895959]
19.: Chirenje ZM, et al. A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. Journal of Obstetrics and Gynaecology. 2001;21(6):617–621. [PubMed: 12521783]
20.: WHO cervical cancer prevention and control costing tool (C4P). Geneva: World Health Organization; 2012. [24 October 2013]. http://www.who.int/nuvi/hpv/cervical_cancer_costing_tool/en/index.html.

All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK195234

Contents

< Prev Next >

PubReader
Print View
Cite this Page
WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva: World Health Organization; 2013. References.
PDF version of this title (762K)